198 related articles for article (PubMed ID: 36196767)
1. Sonazoid™ versus SonoVue
Kang HJ; Lee JM; Yoon JH; Yoo J; Choi Y; Joo I; Han JK
Korean J Radiol; 2022 Nov; 23(11):1067-1077. PubMed ID: 36196767
[TBL] [Abstract][Full Text] [Related]
2. Intra-individual comparison of Sonazoid contrast-enhanced ultrasound and SonoVue contrast-enhanced ultrasound in diagnosing hepatocellular carcinoma.
Guo D; Wan W; Bai X; Wen R; Peng J; Lin P; Liao W; Huang W; Liu D; Peng Y; Kang T; Yang H; He Y
Abdom Radiol (NY); 2024 May; 49(5):1432-1443. PubMed ID: 38584190
[TBL] [Abstract][Full Text] [Related]
3. Contrast-Enhanced Ultrasound With Perfluorobutane for Hepatocellular Carcinoma Diagnosis: Comparison of Imaging Phases and Diagnostic Criteria.
Kang HJ; Lee JM; Yoon JH; Yoo J; Kim JH; Park J
AJR Am J Roentgenol; 2024 Feb; 222(2):e2330156. PubMed ID: 37991335
[No Abstract] [Full Text] [Related]
4. Assessment of arterial-phase hyperenhancement and late-phase washout of hepatocellular carcinoma-a meta-analysis of contrast-enhanced ultrasound (CEUS) with SonoVue® and Sonazoid®.
Ren J; Lu Q; Fei X; Dong Y; D Onofrio M; Sidhu PS; Dietrich CF
Eur Radiol; 2023 Nov; ():. PubMed ID: 37989916
[TBL] [Abstract][Full Text] [Related]
5. Role of Contrast-Enhanced Ultrasound as a Second-Line Diagnostic Modality in Noninvasive Diagnostic Algorithms for Hepatocellular Carcinoma.
Kang HJ; Lee JM; Yoon JH; Han JK
Korean J Radiol; 2021 Mar; 22(3):354-365. PubMed ID: 33236540
[TBL] [Abstract][Full Text] [Related]
6. Washout appearance of hepatocellular carcinomas using standardized contrast-enhanced ultrasound (CEUS) including an extended late phase observation - Real-world data from the prospective multicentre DEGUM study.
Meitner-Schellhaas B; Jesper D; Goertz RS; Zundler S; Strobel D
Clin Hemorheol Microcirc; 2023; 84(4):413-424. PubMed ID: 37334585
[TBL] [Abstract][Full Text] [Related]
7. Perfluorobutane-enhanced ultrasonography with a Kupffer phase: improved diagnostic sensitivity for hepatocellular carcinoma.
Hwang JA; Jeong WK; Kang HJ; Lee ES; Park HJ; Lee JM
Eur Radiol; 2022 Dec; 32(12):8507-8517. PubMed ID: 35705829
[TBL] [Abstract][Full Text] [Related]
8. Contrast-enhanced US with Sulfur Hexafluoride and Perfluorobutane for the Diagnosis of Hepatocellular Carcinoma in Individuals with High Risk.
Kang HJ; Lee JM; Yoon JH; Lee K; Kim H; Han JK
Radiology; 2020 Oct; 297(1):108-116. PubMed ID: 32749211
[TBL] [Abstract][Full Text] [Related]
9. Prospective assessment of diagnostic efficacy and safety of Sonazoid
Lv K; Zhai H; Jiang Y; Liang P; Xu HX; Du L; Chou YH; Xie X; Luo Y; Lee YJ; Lee JY; Hu B; Luo B; Wang Y; Luan Y; Kalli C; Chen K; Wang W; Liang JD
Abdom Radiol (NY); 2021 Oct; 46(10):4647-4659. PubMed ID: 34136936
[TBL] [Abstract][Full Text] [Related]
10. Impact of Hepatocellular Carcinoma Tumor Size on Sonazoid Contrast-Enhanced Ultrasound Enhancement Features.
Chen S; Qiu YJ; Zhang Q; Lu XY; Huang YL; Dong Y; Wang WP
Ultrasound Med Biol; 2024 Jan; 50(1):39-46. PubMed ID: 37778901
[TBL] [Abstract][Full Text] [Related]
11. LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations.
Schellhaas B; Wildner D; Pfeifer L; Goertz RS; Hagel A; Neurath MF; Strobel D
Ultraschall Med; 2016 Dec; 37(6):627-634. PubMed ID: 27486793
[No Abstract] [Full Text] [Related]
12. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
[TBL] [Abstract][Full Text] [Related]
13. Arterial subtraction images of gadoxetate-enhanced MRI improve diagnosis of early-stage hepatocellular carcinoma.
Kim DH; Choi SH; Byun JH; Kang JH; Lim YS; Lee SJ; Kim SY; Won HJ; Shin YM; Kim PN
J Hepatol; 2019 Sep; 71(3):534-542. PubMed ID: 31108157
[TBL] [Abstract][Full Text] [Related]
14. Strategy for Accurate Diagnosis by Contrast-Enhanced Ultrasound of Focal Liver Lesions in Patients Not at High Risk for Hepatocellular Carcinoma: A Preliminary Study.
Xian MF; Li W; Lan WT; Zeng D; Xie WX; Lu MD; Huang Y; Wang W
J Ultrasound Med; 2023 Jun; 42(6):1333-1344. PubMed ID: 36534591
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Accuracy of CEUS LI-RADS for the Characterization of Liver Nodules 20 mm or Smaller in Patients at Risk for Hepatocellular Carcinoma.
Huang JY; Li JW; Lu Q; Luo Y; Lin L; Shi YJ; Li T; Liu JB; Lyshchik A
Radiology; 2020 Feb; 294(2):329-339. PubMed ID: 31793849
[TBL] [Abstract][Full Text] [Related]
16. Parametric imaging with contrast-enhanced ultrasound for differentiating hepatocellular carcinoma from metastatic liver cancer.
Yue WW; Wang S; Xu HX; Sun LP; Guo LH; Bo XW; Li XL; Zhao CK; Wang D; Liu BJ
Clin Hemorheol Microcirc; 2016 Nov; 64(2):177-188. PubMed ID: 27258196
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic criteria of perfluorobutane-enhanced ultrasonography for diagnosing hepatocellular carcinoma in high-risk individuals: how is late washout determined?
Kang HJ; Kim JH; Yoo J; Han JK
Ultrasonography; 2022 Jul; 41(3):530-542. PubMed ID: 35144328
[TBL] [Abstract][Full Text] [Related]
18. Quantification of Hepatocellular Carcinoma Vascular Dynamics With Contrast-Enhanced Ultrasound for LI-RADS Implementation.
Krolak C; Dighe M; Clark A; Shumaker M; Yeung R; Barr RG; Kono Y; Averkiou M
Invest Radiol; 2024 Apr; 59(4):337-344. PubMed ID: 37725492
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of contrast-enhanced intraoperative ultrasound using Sonazoid in patients with hepatocellular carcinoma.
Arita J; Takahashi M; Hata S; Shindoh J; Beck Y; Sugawara Y; Hasegawa K; Kokudo N
Ann Surg; 2011 Dec; 254(6):992-9. PubMed ID: 21694582
[TBL] [Abstract][Full Text] [Related]
20. Can contrast enhanced ultrasound differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma?
Huang JY; Li JW; Ling WW; Li T; Luo Y; Liu JB; Lu Q
World J Gastroenterol; 2020 Jul; 26(27):3938-3951. PubMed ID: 32774068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
